Viewing StudyNCT03606746

Home Icon Home Search Icon Search Alerts Icon Stocks Certify Doc Icon Certify Doc Certify Doc Icon Genes Certify Doc Icon Clinical Trials Certify Doc Icon CompTox Processes Icon DrugMatrix Open Targets Icon Open Targets Processes Icon Products Support Icon Support Bugs Icon Bugs eRecord Icon eRecord
Main Search All Studies All Organizations Report Bug
View Study With Definitions
Ignite Creation Date: 2024-05-06 @ 11:49 AM
Last Modification Date: 2024-10-26 @ 12:50 PM
Study NCT ID: NCT03606746
Status: WITHDRAWN
Last Update Posted: 2024-06-07
First Post: 2018-07-20
Brief Title: Cellular Immunotherapy for Immune Tolerance in Past Recipients of HLA Zero-mismatch Living Donor Kidney Transplants
Sponsor: Medeor Therapeutics Inc
Organization: Medeor Therapeutics Inc
Overview Dates Organization Conditions Design Enrollment Locations Outcomes

Conditions & Keywords Data

Conditions:
Name
Kidney Transplant Rejection
Keywords:
Name View
Immunosuppression View
Kidney Transplant View
Kidney Failure View
Anti-rejection therapy View
Living Donor View
HLA-matched View
Hematopoietic Stem Cells HSC View
CD34 View
CD3 View
T cells View
Cellular Therapy View
Immunotherapy View